- Home
- CRMD vs BOE Comparison
CRMD vs BOE Comparison
Compare CRMD & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | BOE |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 649.4M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRMD | BOE |
|---|---|---|
| Price | $7.87 | $11.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 90.0K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.30% |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.72 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $10.59 |
| 52 Week High | $14.96 | $12.35 |
Technical Indicators
Market Signals| Indicator | CRMD | BOE |
|---|---|---|
| Relative Strength Index (RSI) | 42.72 | 44.44 |
| Support Level | $7.50 | $11.74 |
| Resistance Level | $9.02 | $12.07 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 13.57 | 20.42 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust is a closed-end management investment company. Its investment objective is to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. The Trust seeks to achieve its investment objectives by investing in equity securities issued by companies located in countries throughout the world.